Department of Pathological Anatomy

Medicine & Life Sciences

1. Indonesia 100%
2. Breast Neoplasms 41%
3. Neoplasms 40%
4. Uterine Cervical Neoplasms 28%
5. Colorectal Neoplasms 22%
6. Carcinoma 19%
7. Neoplasm Metastasis 19%
8. Immunohistochemistry 18%
9. Dextran Sulfate 18%
10. Staining and Labeling 17%
11. Skin Neoplasms 16%
12. Colon 16%
13. Lymphoma 16%
14. Cell Line 16%
15. Bone and Bones 16%
16. Apoptosis 15%
17. Squamous Cell Carcinoma 14%
18. Caspase 3 13%
19. Japan 13%
20. Pleural Empyema 13%
21. Biopsy 12%
22. Human Herpesvirus 4 12%
23. Proteins 12%
24. Lymphoma, Large B-Cell, Diffuse 12%
25. Lymph Nodes 12%
26. Control Groups 11%
27. Adenocarcinoma 11%
28. Liver 11%
29. Catenins 11%
30. Carcinogenesis 10%
31. Cell Biology 10%
32. Paraffin 9%
33. Survival 9%
34. Inflammation 9%
35. Osteosarcoma 9%
36. B-Lymphocytes 9%
37. Therapeutics 9%
38. Melanoma 9%
39. Mutation 9%
40. Drug Therapy 9%
41. Ethanol 9%
42. Hepatocellular Carcinoma 9%
43. Pathology 9%
44. Mesenchymal Stem Cells 8%
45. Ductal Carcinoma 8%
46. Cyclooxygenase 2 8%
47. Case-Control Studies 8%
48. Anti-Inflammatory Agents 8%
49. Fibrosis 8%
50. Sprague Dawley Rats 8%
51. Annona 7%
52. antimycin 7%
53. Azoxymethane 7%
54. Fruit 7%
55. Population 7%
56. Epidemiologic Studies 7%
57. Wistar Rats 7%
58. Cell Proliferation 7%
59. Breast 7%
60. Lymphocytes 7%
61. Chronic Hepatitis B 7%
62. Skin 7%
63. Basal Cell Carcinoma 7%
64. Genes 7%
65. Endometrioid Carcinoma 7%
66. Eosine Yellowish-(YS) 7%
67. Chitosan 7%
68. Natural Killer Cells 7%
69. Tuberculosis 7%
70. Embryonal Rhabdomyosarcoma 7%
71. Keratin-19 6%
72. Recurrence 6%
73. nucleolar organizer region associated proteins 6%
74. In Vitro Techniques 6%
75. Cancer-Associated Fibroblasts 6%
76. Cadherins 6%
77. Sensitivity and Specificity 6%
78. Epidemiology 6%
79. Cancer Care Facilities 6%
80. DNA 6%
81. Polyps 6%
82. Incidence 6%
83. Mitosis 6%
84. Fetal Blood 6%
85. Wounds and Injuries 6%
86. T-Cell Lymphoma 6%
87. General Hospitals 6%
88. Liposarcoma 6%
89. Middle Cerebral Artery Infarction 6%
90. Sarcoma 6%
91. T-Lymphocytes 6%
92. Cross-Sectional Studies 5%
93. Limb Salvage 5%
94. Contraceptive Agents 5%
95. Blood Cells 5%
96. Endometrium 5%
97. Hematoxylin 5%
98. Ovarian Epithelial Carcinoma 5%
99. NF-kappa B 5%
100. Fas Ligand Protein 5%